Final-Program-ATS-2023-AP.vp

TUESDAY • MAY 23

233

408 Pulmonary Rehabilitation Uptake Following Hospitalization for COPD Exacerbation: Numbers Are Not so Dismal as We Might Think/ O. Elsankary, North Haven, CT 409 The Effect of Obesity on Exercise Performance in a Cardiac Rehabilitation Program/ N. Mittal, La Jolla, CA 410 Muscular Performance Is Impaired Relative to Disease Severity in Idiopathic Pulmonary Fibrosis and Is Associated With Reduced Levels of Moderate-to-Vigorous Physical Activity/ M.B. Brown, Seattle, WA 411 A Pilot Study Using Aspects of Virtual Pulmonary Rehabilitation to Complement Remote Physiologic Monitoring in COPD/ N. Moraveji, San Francisco, CA 412 Socioeconomic Status and Pulmonary Rehabilitation Completion/ E. Vasko, North Haven, CT 413 Evaluation of Work of Breathing and Health Care Utilization in Patients Prescribed Daily Oscillation and Lung Expansion (OLE) Therapy at Home/ B.C. Becker, St. Paul, MN

124 Impaired Endothelial Purinergic-TRPV4 Channel Signaling Reduces Flow-Induced Dilation of Resistance Pulmonary Arteries in Pulmonary Hypertension/ Z. Daneva, Charlottesville, VA 125 Augmentation of Kindlin-2 Expression Attenuates Endothelial Cell Permeability and Murine Acute Lung Injury/ W. Chen, Chicago, IL

BEHAVIORAL • CLINICAL POSTER DISCUSSION SESSION

C27

OPTIMIZING THE INTERVENTIONS AND PROGRAM MODELS OF PULMONARY REHABILITATION

9:00 a.m. - 11:00 a.m.

Walter E. Washington Convention Center Room 151 A (Street Level)

Poster Viewing

9:00-9:45 9:45-11:00

Discussion

Chairing: C.L. Goulart, PhD, Sao Carlos, Brazil

M. Steiner, MBBS, MD, FRCP, Leicester, United Kingdom 401 Effectiveness of Oscillating Positive Expiratory Pressure Device in Bronchiectasis With Frequent Exacerbation/ S.R. Kim, Cheongju-si, Korea, Republic of 402 Telerehabilitation in the ‘Real World’: Implementation of Remotely Delivered Pulmonary Rehabilitation/ N.S. Cox, Melbourne, Australia 403 Are We Maximising the Potential of Occupational Therapists to In Deliver Patient Education In Pulmonary Rehabilitation?/ N.J. Roberts, Edinburgh, United Kingdom 404 Comparison of Cardiopulmonary and Symptom Responses Between Three Types of Exercise Tests in Interstitial Lung Disease/ A. Nakazawa, Yokohama, Japan 405 Understanding Provider-level Barriers and Enablers Impacting the Referral of Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease to Pulmonary Rehabilitation, in Safety-net Healthcare Settings/ M.H. Siddeek, San Francisco, CA 406 Effect of Virtual Pulmonary Rehabilitation Among Patients With Chronic Obstructive Pulmonary Disease/ A.J.S. Almario, Quezon City, Philippines 407 Assessment of the Clinical Value of an Oscillating Positive Expiratory Pressure (OPEP) Device for Chronic Obstructive Pulmonary Disease (COPD) Patients in India: A 6 Week Field Study Using the COPD Assessment Test (CAT)/ J. Suggett, London, Canada

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

C28

FROM OMICS TO EX VIVO MODELS: A ROAD MAP FOR NOVEL THERAPIES IN LUNG FIBROSIS

9:00 a.m. - 11:00 a.m.

Marriott Marquis Washington Marquis Ballroom, Salons 9-10 (Level M2)

Poster Viewing

9:00-9:45 9:45-11:00

Discussion

Chairing: M. Koenigshoff, MD, PhD, ATSF, Pittsburgh, PA D.J. Tschumperlin, PhD, Rochester, MN K.-D. Alysandratos, MD, PhD, Boston, MA 1001 Epithelial Outgrowth Through Mesenchymal Rings Drives Alveologenesis/ N. Negretti, Nashville, TN 1002 Development and Characterization of a Feeder-free System to Study Goblet Cell Variant Basal Cells/ T.S. Tufenkjian, Nashville, TN 1003 Establishing Airway Lung Organoids From Human Bronchoalveolar Lavage Fluid/ M.Y. Liu, Boston, MA 1004 A Multi-Lineage Airway Culture System Using Human Induced Pluripotent Stem Cells/ D.J. Wallman, Boston, MA

ATS 2023 • Washington, DC